Parameter
| Biomarker | miR-375-3p (EV) | Full name | microRNA-375-3p (extracellular vesicle source) | Molecular Type | Nucleic acid (miRNA, EV packaged) |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | Diagnosis and monitoring |
| Disease | Diabetes Mellitus | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Serum (qRT - PCR) | ||
| Pathobiological Mechanisms | Islet beta cells damage after release, reflecting the state of beta cell function | ||||
| Clinical Availability Status | In the clinical research stage, it is expected to be used for early screening of LADA and dynamic monitoring of β cell function | ||||
| Notes and Dynamics | The specific markers of early β-cell damage of LADA are expected to be used for early screening | ||||